Real-World Evidence, Social Determinants of Health, and Digital Biomarkers in Driving Patient Recruitment

Real-World Evidence, Social Determinants of Health, and Digital Biomarkers in Driving Patient Recruitment

This IDC Perspective reviews the paradigm shift of the life sciences industry from conventional models to patient recruitment strategies that focus on using RWD, leveraging SDoH to drive diversity and equity in clinical trials, and the significant potential of digital biomarkers in driving patient recruitment. It reviews the factors that need to be taken into consideration when using RWD and the key players in this space and provides guidance to technology buyers as well."The use of RWD to refine eligibility criteria and optimize patient recruitment is becoming the new normal. Leveraging SDoH to drive diversity in clinical trials, and the use of digital biomarkers, especially for recruiting patients with neurological diseases, are the bellwether of a coming revolution in clinical trial recruitment strategy," says Dr. Nimita Limaye, research VP, Life Sciences R&D Strategy and Technology at IDC Health Insights.

Please Note: Extended description available upon request.


Executive Snapshot
Situation Overview
Real-World Data
Social Determinants of Health
Digital Biomarkers
Advice for the Technology Buyer
Learn More
Related Research
Synopsis

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings